TFF Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	5.48	16.61	33.79	35.3	28.09	10.26	0
Cash & Cash Equivalents	5.48	16.61	33.79	35.3	28.09	10.26	0
Cash Growth	-67.02%	-50.84%	-4.27%	25.65%	173.79%	-	-
Receivables	0	0	1.63	0	0	0	0
Other Current Assets	2.11	2.41	3.41	2.26	1.09	0.01	0
Total Current Assets	7.59	19.03	38.84	37.56	29.19	10.27	0
Property, Plant & Equipment	2.12	3.27	1.86	1.1	0	0	0
Long-Term Investments	2.31	1.81	0	0	0	0	0
Other Long-Term Assets	0.01	0.01	0	0	0	0.13	0
Total Long-Term Assets	4.44	5.1	1.86	1.1	0	0.13	0
Total Assets	12.03	24.12	40.7	38.66	29.19	10.4	0
Accounts Payable	0.96	0.92	1.49	1.3	0.41	1.16	0
Deferred Revenue	0.1	0.13	0.05	0.02	0	0	0
Current Debt	0.08	0.08	0	0	0	0	0
Other Current Liabilities	1.29	0	0.42	0	0	0	0
Total Current Liabilities	2.43	1.13	1.96	1.32	0.41	1.16	0
Long-Term Debt	0.03	0.11	0	0	0	0	0
Other Long-Term Liabilities	0	0	0	0	1.13	0	0
Total Long-Term Liabilities	0.03	0.11	0	0	1.13	0	0
Total Liabilities	2.46	1.24	1.96	1.32	1.54	1.16	0
Total Debt	0.12	0.19	0	0	0	0	0
Debt Growth	-39.57%	-	-	-	-	-	-
Retained Earnings	-118.33	-97.09	-65.32	-34.28	-15.71	-3.84	0
Comprehensive Income	-0.15	-0.14	-0.05	-0.05	0	0	0
Shareholders' Equity	9.57	22.88	38.74	37.34	27.64	-3.24	-0
Net Cash / Debt	5.36	16.42	33.79	35.3	28.09	10.26	0
Net Cash / Debt Growth	-67.34%	-51.41%	-4.27%	25.65%	173.79%	-	-
Net Cash Per Share	2.99	13.69	34.04	43.21	101.72	73.64	-
Working Capital	5.16	17.89	36.88	36.24	28.78	9.12	-0
Book Value Per Share	5.34	19.08	39.02	45.70	100.09	-23.26	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).